Crossref journal-article
Elsevier BV
Journal of Allergy and Clinical Immunology (78)
Bibliography

Nopp, A., Halldén, G., Lundahl, J., Johansson, E., Vrtala, S., Valenta, R., Grönneberg, R., & van Hage-Hamsten, M. (2000). Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients. Journal of Allergy and Clinical Immunology, 106(1), 101–109.

Authors 8
  1. Anna Nopp (first)
  2. Gunilla Halldén (additional)
  3. Joachim Lundahl (additional)
  4. Eva Johansson (additional)
  5. Susanne Vrtala (additional)
  6. Rudolf Valenta (additional)
  7. Reidar Grönneberg (additional)
  8. Marianne van Hage-Hamsten (additional)
References 37 Referenced 39
  1. 10.1111/j.1398-9995.1989.tb04169.x / Allergy / IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa by Jarolim (1989)
  2. 10.1159/000237561 / Int Arch Allergy Immunol / Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries by Elfman (1997)
  3. 10.1002/j.1460-2075.1989.tb03597.x / EMBO J / The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea diseases resistance response gene by Breiteneder (1989)
  4. 10.1172/JCI119330 / J Clin Invest / Conversion of the major birch pollen allergen, Bet v 1, into two non-anaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy by Vrtala (1997)
  5. 10.1159/000024075 / Int Arch Allergy Immunol / Genetic engineering of recombinant hypoallergenic oligomers of the major pollen allergen, Bet v 1: candidates for specific immunotherapy by Vrtala (1999)
  6. 10.1016/S0091-6749(99)70077-1 / J Allergy Clin Immunol by van Hage-Hamsten (1999)
  7. Pauli G, Purohit A, Oster J-P, De Blay F, Vrtala S, Niederberger V, et al. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wildtype by skin prick and intradermal testing: results obtained in a French population. Clin Exp Allergy. In press.
  8. 10.1136/pgmj.70.826.536 / Postgrad Med J / Eosinophils in the 1990s: new perspectives on their role in health and disease by Wardlaw (1994)
  9. {'key': '10.1067/mai.2000.106924_bib9', 'first-page': '373', 'article-title': 'Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions', 'volume': '131', 'author': 'De Monchy', 'year': '1985', 'journal-title': 'Am Rev Respir Dis'} / Am Rev Respir Dis / Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions by De Monchy (1985)
  10. 10.1164/ajrccm/147.5.1126 / Am Rev Respir Dis / Cellular and biochemival analysis of induced sputum from asthmatic and from healthy subjects by Fahy (1993)
  11. 10.1164/ajrccm.154.1.8680684 / Am J Respir Crit Care Med / Cellular infiltration of the airways of varying severity by Synek (1999)
  12. {'key': '10.1067/mai.2000.106924_bib12', 'first-page': '281', 'article-title': 'CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines', 'volume': '80', 'author': 'Hartnell', 'year': '1993', 'journal-title': 'Immunology'} / Immunology / CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines by Hartnell (1993)
  13. 10.1016/0091-6749(92)90068-D / J Allergy Clin Immunol / In vivo expression on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils by Nishikawa (1992)
  14. 10.1016/S0091-6749(96)70270-1 / J Allergy Clin Immunol / Anti-IgE-induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjects by Raud (1996)
  15. 10.1046/j.1365-2222.1999.00572.x / Clin Exp Allergy / Characterisation of eosinophils and detection of eotaxin in skin chamber fluid after challenge with relevant allergen in patients with mild asthma by Fernvik (1999)
  16. 10.1006/prep.1996.0671 / Protein Expr Purif / High-level expression and purification of the major birch pollen allergen, Bet v 1 by Hoffmann-Sommergruber (1997)
  17. 10.1016/0022-1759(89)90191-9 / J Immunol Meth / A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry by Halldén (1989)
  18. 10.1111/j.1398-9995.1993.tb04707.x / Allergy / Counts of activated blood eosinophils for monitoring asthma by Hed (1993)
  19. {'key': '10.1067/mai.2000.106924_bib19', 'first-page': '455', 'article-title': 'Allergen induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of IL-4 and sVCAM-1', 'volume': '54', 'author': 'Fernvik', 'year': '1999', 'journal-title': 'Allergy'} / Allergy / Allergen induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of IL-4 and sVCAM-1 by Fernvik (1999)
  20. 10.1165/ajrcmb.21.3.f160 / Am J Respir Cell Mol Biol / Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissue by Rothenberg (1999)
  21. 10.1038/309182a0 / Nature / Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein by Tai (1984)
  22. 10.1002/jlb.66.3.447 / J Leukoc Biol / Reactivity of monoclanal antibodies EG1 and EG2 with eosinophils and their granule proteins by Nakajima (1999)
  23. {'key': '10.1067/mai.2000.106924_bib23', 'first-page': '250', 'article-title': 'Eosinophil activity reflects clinical status in patients with asthma before and during a predisolone course', 'volume': '75', 'author': 'Skedinger', 'year': '1995', 'journal-title': 'Ann Allergy Asthma Immunol'} / Ann Allergy Asthma Immunol / Eosinophil activity reflects clinical status in patients with asthma before and during a predisolone course by Skedinger (1995)
  24. 10.1111/j.1398-9995.1996.tb04450.x / Allergy / The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma by Fernvik (1996)
  25. 10.1016/S1081-1206(10)62839-6 / Ann Allergy Asthma Immunol / Conditions in blood sampling conditions that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls by Halldén (1999)
  26. 10.1023/A:1006940109869 / Inflammation / The impact of eotaxin- and IL5-induced adhesion and transmigration of eosinophil activity markers by Fernvik (2000)
  27. 10.1034/j.1398-9995.2000.00363.x / Allergy / Quantitative, rather than qualitative, differences in CD69 upregulation in human blood eosinophils upon activation with selected stimuli by Nopp (2000)
  28. 10.1007/s000110050383 / Inflamm Res / The effect of in vitro activation and platelet interaction on the CD9 distribution and adhesion properties of human eosinophils by Fernvik (1999)
  29. 10.1084/jem.174.3.745 / J Exp Med / Granulocyte/machrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils by Kita (1991)
  30. 10.1136/thx.54.9.825 / Thorax / Cytokines in asthma by Chung (1999)
  31. 10.4049/jimmunol.155.10.4939 / J Immunol / Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product by Moqbel (1995)
  32. 10.1016/S0091-6749(95)70037-4 / J Allergy Clin Immunol / Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late phase reactions by Vowels (1995)
  33. 10.1016/S0091-6749(97)70201-X / J Allergy Clin Immunol / Cytokine levels and inflammatory responses in developing late-phase reactions in the skin by Zweiman (1997)
  34. 10.1016/S0091-6749(98)70248-9 / J Allergy Clin Immunol / Immunohistochemical detection of human basophils in late-phase skin reactions by Irani (1998)
  35. 10.4049/jimmunol.146.2.671 / J Immunol / Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen by Charlesworth (1991)
  36. 10.4049/jimmunol.163.7.3976 / J Immunol by Ying (1999)
  37. 10.1016/S0091-6749(95)70192-3 / J Allergy Clin Immunol / Chronologic analysis of in situ cytokine expression in mite allergen–induced dermatitis in atopic subjects by Yamada (1995)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 12:20 a.m.)
Deposited 2 years, 4 months ago (April 3, 2023, 11:12 a.m.)
Indexed 1 year ago (Aug. 29, 2024, 9:50 a.m.)
Issued 25 years, 2 months ago (July 1, 2000)
Published 25 years, 2 months ago (July 1, 2000)
Published Print 25 years, 2 months ago (July 1, 2000)
Funders 0

None

@article{Nopp_2000, title={Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients}, volume={106}, ISSN={0091-6749}, url={http://dx.doi.org/10.1067/mai.2000.106924}, DOI={10.1067/mai.2000.106924}, number={1}, journal={Journal of Allergy and Clinical Immunology}, publisher={Elsevier BV}, author={Nopp, Anna and Halldén, Gunilla and Lundahl, Joachim and Johansson, Eva and Vrtala, Susanne and Valenta, Rudolf and Grönneberg, Reidar and van Hage-Hamsten, Marianne}, year={2000}, month=jul, pages={101–109} }